dc.contributor.author | Soyer, N. | |
dc.contributor.author | Turgut, M. | |
dc.contributor.author | Haznedaroglu, I. | |
dc.contributor.author | Yilmaz, F. | |
dc.contributor.author | Aydogdu, I. | |
dc.contributor.author | Pir, A. | |
dc.contributor.author | Yavasoglu, I. | |
dc.contributor.author | Karakuş, Volkan | |
dc.date.accessioned | 2020-11-20T14:51:46Z | |
dc.date.available | 2020-11-20T14:51:46Z | |
dc.date.issued | 2017 | |
dc.identifier.issn | 0145-2126 | |
dc.identifier.issn | 1873-5835 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12809/1805 | |
dc.description | 8th International Eurasian Hematology Oncology Congress (EHOC) - OCT 18-21, 2017 - Istanbul, TURKEY | en_US |
dc.description | WOS: 000416742600048 | en_US |
dc.item-language.iso | eng | en_US |
dc.publisher | Pergamon-Elsevier Science Ltd | en_US |
dc.item-rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | EFFICACY AND SAFETY OF RUXOLITINIB IN TURKISH PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A MULTICENTER AND RETROSPECTIVE ANALYSIS | en_US |
dc.item-type | conferenceObject | en_US |
dc.contributor.department | MÜ, Eğitim ve Araştırma Hastanesi | en_US |
dc.contributor.institutionauthor | Karakuş, Volkan | |
dc.identifier.volume | 61 | en_US |
dc.identifier.startpage | S19 | en_US |
dc.identifier.endpage | S19 | en_US |
dc.relation.journal | Leukemia Research | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |